Accumulating evidence has confirmed that FZD7 can mediate the activation of the canonical WNT/β-catenin signaling in breast, colorectal, and hepatocellular carcinoma (King et al. 2012). This evidence concerns the gene FZD7 and hepatocellular carcinoma.